{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/49702-246#drug","name":"Dovato","alternateName":"dolutegravir sodium and lamivudine","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"49702-246"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA211994"},{"@type":"PropertyValue","propertyID":"UNII","value":"1Q1V9V5WYQ|2T8Q726O95"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"68e45422-43ed-4cfb-9356-fae88d14a53a"}],"activeIngredient":"DOLUTEGRAVIR SODIUM, LAMIVUDINE","administrationRoute":["ORAL"],"dosageForm":"TABLET, FILM COATED","manufacturer":{"@type":"Organization","name":"ViiV Healthcare Company"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA211994","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=68e45422-43ed-4cfb-9356-fae88d14a53a","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=49702-246"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T14:32:34.246Z"}}